NCT03018405 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03018405
Title	A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications (THINK)
Acronym	THINK
Recruitment	Unknown status
Gender	both
Phase	Phase Ib/II
Variant Requirements	No
Sponsors	Celyad Oncology SA
Indications	ovary epithelial cancer colorectal cancer triple-receptor negative breast cancer transitional cell carcinoma multiple myeloma acute myeloid leukemia pancreatic cancer fallopian tube carcinoma myelodysplastic syndrome
Therapies	NKR-2 cells
Age Groups:	adult \| senior
Covered Countries	USA \| BEL

NCT03018405
Clinical Trial Detail